Insight Biotechnology search:

<<First <Prev Next> Last>>

Search Results for:
Catalogue No	Partner	Description	Species	Application
HY-147158-100mg	MedChemexpress LLC	ZXH-1-161 [CAS 2407654-51-5]		Cancer-programmed cell death
HY-147158-25mg	MedChemexpress LLC	ZXH-1-161 [CAS 2407654-51-5]		Cancer-programmed cell death
HY-147158-5mg	MedChemexpress LLC	ZXH-1-161 [CAS 2407654-51-5]		Cancer-programmed cell death
HY-147158-50mg	MedChemexpress LLC	ZXH-1-161 [CAS 2407654-51-5]		Cancer-programmed cell death
HY-147158-1mL	MedChemexpress LLC	ZXH-1-161 [CAS 2407654-51-5] (10mM in DMSO)		Cancer-programmed cell death
HY-122826-10mg	MedChemexpress LLC	ZXH-3-26 [CAS 2243076-67-5]		Cancer-programmed cell death
HY-122826-100mg	MedChemexpress LLC	ZXH-3-26 [CAS 2243076-67-5]		Cancer-programmed cell death
HY-122826-5mg	MedChemexpress LLC	ZXH-3-26 [CAS 2243076-67-5]		Cancer-programmed cell death
HY-122826-50mg	MedChemexpress LLC	ZXH-3-26 [CAS 2243076-67-5]		Cancer-programmed cell death
HY-132857A-10mg	MedChemexpress LLC	ZXH-4-130 (TFA) [CAS 2711006-67-4]		Neuroscience-Neuromodulation
HY-132857A-100mg	MedChemexpress LLC	ZXH-4-130 (TFA) [CAS 2711006-67-4]		Neuroscience-Neuromodulation
HY-132857A-25mg	MedChemexpress LLC	ZXH-4-130 (TFA) [CAS 2711006-67-4]		Neuroscience-Neuromodulation
HY-132857A-5mg	MedChemexpress LLC	ZXH-4-130 (TFA) [CAS 2711006-67-4]		Neuroscience-Neuromodulation
HY-132857A-50mg	MedChemexpress LLC	ZXH-4-130 (TFA) [CAS 2711006-67-4]		Neuroscience-Neuromodulation
HY-144088-1mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation
HY-144088-10mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation
HY-144088-100mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation
HY-144088-25mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation
HY-144088-5mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation
HY-144088-50mg	MedChemexpress LLC	ZYF0033 [CAS 2380300-79-6]		COVID-19-immunoregulation